Jennifer Robinson

powered by
COS Expertise®
University of Iowa
College of Public Health
Epidemiology
Associate ProfessorAppointed: 2003
University of Iowa
Carver College of Medicine
Department of Medicine
Division of Cardiology
Associate ProfessorAppointed: 2004
University of Iowa
College of Public Health
Epidemiology
Lipid Research Clinic
Program DirectorAppointed: 2003
Foundation for Health Advocacy
FounderAppointed: 2002
Foundation for Health Advocacy
PresidentAppointed: 2002
Iowa State University
College of Human Sciences
Food Science & Human Nutrition-HS
Scientific CollaboratorAppointed: 1999

Mailing Address

Founder and President
SE 226 General Hospital
University of Iowa
Iowa City, Iowa 52242
United States

Contact Information

Phone: (319) 384-5004
Fax: (319) 384-5004
jennifer-g-robinson@uiowa.edu
http://www.public-health.uiowa.edu/faculty-staff/faculty/directory/faculty-detail.asp?emailAddress=jennifer-g-robinson@uiowa.edu

Qualifications

M.P.H., University of Minnesota, Epidemiology, 1995.
M.D., University of Minnesota, 1987.
B.A., Northwestern University, Political Science, 1982.

Expertise and Research Interests

Areas of Research Interest/Current Projects
1. Drugs affecting atherosclerosis and metabolism
2. Management of cardiovascular risk factors
3. Cardiovascular prevention in the elderly
4. Cardiovascular risk prediction
5. Multilevel compliance challenge of global risk factor management
6. Internet-based patient and healthcare professional education program
7. Social and environmental factors affecting healthy lifestyle choices

Other Expertise

Chapters

1. Davidson MH, Robinson JG. Cholesterol. In Toth P, Gotto A, eds. Prevention of High-Risk Cardiovascular Disease 2006.

2. Robinson JG. Should we treat dyslipidemia in the elderly? In Toth P, Sica D, eds. Clinical challenges in Dyslipidemia Management 2008, in press.

3. Robinson JG. Chapter XXI. Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease. In Kwiterovich P, ed. The Johns Hopkins Textbook of Dyslipidemia. Lippincott, Williams and Wilkins. 2009, in press.
Contribution:

Future Research

Web-based education and tracking system for patients to self-manage cardiovascular risk factors.
Web-based system for healthcare providers for continuing medical education and tracking patient risk factors.

Industrial Relevance

Research into systems to improve patient adherence to cholesterol, blood pressure, and glucose-lowering medication prescriptions; as well as research into improving healthcare provider implementation of evidence-based guidelines for drug utilization for cardiovascular prevention.

Keywords

COS Keywords:

Cardiovascular System, Epidemiology, Risk Factor Analysis.

Additional Terms:

Cardiovascular Epidemiology, Cardiovascular Prevention, Cardiovascular Risk Assessment, Cardiovascular Risk Prevention, Compliance, Global Risk Factor Management, Lipids, Obesity and Diabetes, Social and Environmental Factors Affecting Lifestyle Choices.

Memberships

American College of Physicians
American Heart Association
American Medical Association
American Medical Informatics Association
American Society for Preventive Cardiology
American Society of Geriatric Cardiology
Central Society for Clinical Research
Iowa Medical Society
Midwest Lipid Association
National Lipid Association
Polk County Medical Society

Honors and Awards

2007, Outstanding Mentor Award, Epidemiology Student Association, College of Public Health, University of Iowa
2007, Outstanding Educator Award, Epidemiology Student Association, College of Public Health, University of Iowa
1986, Alpha Omega Alpha Honor Society,

Previous Positions

1998-2002, Guest Lecturer, Drake University, Nurse Practitioner Training Program
1998-1999, Guest Lecturer, University of Osteopathic Medicine and Health Sciences
1998-2002, Adjunct Assistant Professor, University of Iowa, College of Public Health, Epidemiology
1997-2002, Staff Physician, Mary Greeley Medical Center
1996-2002, Medical Director, Iowa Health Centers, P.C., Preventive Medicine and Research
1996-2003, Staff Physician, Broadlawns Medical Center
1996-2003, Consultant in Lipidology, Iowa Health Centers, P.C.
1996-2003, Courtesy Staff Physician, Mercy Hospital Medical Center
1994-1995, Adjunct Assistant Professor, University of Minnesota, Medical School, Kinesiology
1992-1995, Associate Director, University of Minnesota, Medical School, Heart Disease Prevention Clinic
1992-1995, Clinical Instructor, University of Minnesota, Medical Schoo
1990-1992, Staff Physician, Group Health, Inc., Internal Medicine
1987-1990, Resident, University of Minnesota, Hospitals and Clinics

Publications

  • Tindle HA, Chang YF, Kuller LH, Manson JE, Robinson JG, Rosal MC, Siegle GJ, Matthews KA (Aug 2009) Optimism, Cynical Hostility, and Incident Coronary Heart Disease and Mortality in the Women's Health Initiative., Circulation Abstract
  • Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM (Jun 2009) Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)., The American journal of cardiology, 103 (12), 1694-702 Abstract
  • Robinson JG, Fox KM, Grandy S (2009) Attitudes about health and health-related behaviors in patients with cardiovascular disease or at elevated risk for cardiovascular disease., Preventive cardiology, 12 (3), 136-43 Abstract
  • Robinson JG (2009) Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin., Vascular health and risk management, 5 (1), 31-43 Abstract
  • Robinson JG, Wang S, Smith BJ, Jacobson TA (Jan 2009) Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk., Journal of the American College of Cardiology, 53 (4), 316-22 Abstract
  • Hsia J, Ockene J, Sarto G, Allison M, Hendrix S, Robinson JG, LaCroix A, Manson J, Davies R, Tranza FT, Smith J (2009) Heart rate - a simple risk stratification test, BMJ, In Press
  • Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C, for the Women's Health Initiative Memory Study (Jan 2009) Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study., Neurology, 72 (2), 135-42 Abstract
  • Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, Wallace RB, Lao Z, Freeman R, Stefanick ML, Shumaker SA, for the Women's Health Initiative Memory Study (Jan 2009) Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study., Neurology, 72 (2), 125-34 Abstract
  • Robinson JG (Jan 2009) Is a statin as part of a polypill the answer?, Current atherosclerosis reports, 11 (1), 15-22 Abstract
  • Allison MA, Manson JE, Langer RD, Aragaki A, Smoller S, Lewis CE, Thomas A, Lawson W, Cochrane BB, Hsia J, Hunt JR, Robinson J (Nov 2008) Association between different measures of blood pressure and coronary artery calcium in postmenopausal women., Hypertension, 52 (5), 833-40 Abstract
  • Johnson C, Waters DD, DeMicco DA, Breazna A, Bittner V, Greten H, Grundy SM, LaRosa JC, for the Treating to New Targets Study Steering Committee and Investigators (Nov 2008) Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study), The American journal of cardiology, 102 (10), 1312-7 Abstract
  • Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, Beresford SA, Connelly SA, Curb JD, Grimm RH, Kotchen TA, Kuller LH, Wassertheil-Smoller S, Thomson CA, Torner JC, Women's Health Initiative Investigators (Nov 2008) Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial., Hypertension, 52 (5), 847-55 Abstract
  • Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators (Nov 2008) Calcium plus vitamin D supplementation and the risk of breast cancer., Journal of the National Cancer Institute, 100 (22), 1581-91 Abstract
  • Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J (Nov 2008) Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy., Archives of internal medicine, 168 (20), 2245-53 Abstract
  • Robinson JG (Nov 2008) LDL reduction: how low should we go and is it safe?, Current cardiology reports, 10 (6), 481-7 Abstract
  • Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT, Women's Health Initiative (Oct 2008) Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial., Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 17 (10), 2609-18 Abstract
  • Brunner RL, Cochrane B, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R, Women's Health Initiative Investigators (Sep 2008) Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative., Journal of the American Dietetic Association, 108 (9), 1472-9 Abstract
  • Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG (Sep 2008) Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials)., The American journal of cardiology, 102 (6), 693-9 Abstract
  • Hsia J, Otvos JD, Rossouw JE, Wu L, Wassertheil-Smoller S, Hendrix SL, Robinson JG, Lund B, Kuller LH, Women's Health Initiative Research Group (2008) Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women's Health Initiative Hormone Trials, Arteriosclerosis, thrombosis, and vascular biology, 9, 1666-71 Abstract
  • Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton CP, Prineas R, Robinson JG, Wassertheil-Smoller S (Aug 2008) A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study., Journal of the American Geriatrics Society, 56 (8), 1449-58 Abstract
  • Luo J, Margolis KL, Adami HO, LaCroix A, Ye W, Women's Health Initiative (Aug 2008) Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States)., British journal of cancer, 99 (3), 527-31 Abstract
  • Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SA, Robinson JG, Rodríguez B, Safford MM, Wenger NK, Stevens VJ, Parker LM (Jul 2008) Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial., Archives of internal medicine, 168 (14), 1500-11 Abstract
  • Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SA, Robinson JG, Rodríguez B, Safford MM, Wenger NK, Stevens VJ, Parker LM (Jul 2008) Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial., Archives of internal medicine, 168 (14), 1500-11 Abstract
  • Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W, Women's Health Initiative (Jul 2008) Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux., Gastroenterology, 135 (1), 72-81 Abstract
  • Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, for the TNT and IDEAL Study Groups (Jun 2008) Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment., Circulation, 117 (23), 3002-9 Abstract
  • Bray PF, Larson JC, Lacroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD, Margolis KL, Women's Health Initiative (Jun 2008) Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events., The American journal of cardiology, 101 (11), 1599-1605 Abstract
  • Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V, for the Treating to New Targets Study Steering Committee and Investigators (Apr 2008) Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study., Heart (British Cardiac Society), 94 (4), 434-9 Abstract
  • deBoer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, Larson JC, Manson JE, Margolis KL, Siscovick DS, Weiss NS, Women's Health Initiative Investigators (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative, Diabetes Care, 31 (4), 701-7
  • Robinson JG (Apr 2008) Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk., The American journal of cardiology, 101 (7), 1009-15 Abstract
  • Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, Howard BV, Women's Health Initiative Investigators (Mar 2008) Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials., Arthritis and rheumatism, 59 (3), 302-10 Abstract
  • Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gilligan MA, Gillian MA, Walsh BW, Chen C, McTiernan A, Women's Health Initiative Investigators (Feb 2008) Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy., Archives of internal medicine, 168 (4), 370-7; quiz 345 Abstract
  • Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillipis L, Cochrane BB, Eaton CB, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson RD, Johnson KC, Kuller LH, Robinson JG, for the Women's Health Initiative (WHI) and WHI-Coronary Artery calcium Study Investigators (Jul-Aug 2008) Oophorectomy, Hormone Therapy and Subclinical Coronary Artery Disease in Women with Hysterectomy: The Women's Health Initiative Coronary Artery Calcium Study, Menopause, 15 (4 Pt 1), 639-47
  • Margolis KL, Lihong Qi, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin Liu, Robinson JG, Safford MM, Tinker LT, Phillips LS (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements., Clinical trials (London, England), 5 (3), 240-7 Abstract
  • Bazzata DD, Robinson JG, Fox KM, Grandy S, for the SHIELD Investigators (Nov-Dec 2008) Affecting Behavior Change in Individuals with Diabetes:Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD), Diab Educ, 34 (6), 1025-36
  • Shepherd J, Kastelein JJP, Bittner VA, Carmena RA, Deedwania PC, Breazna AC, Dobson SC, Wilson DJ, Zuckerman AL, Wenger NK, for the Treating to New Targets Study Steering Committee and Investigators (2008) Zuckerman AL, Wenger NK, for the Treating to New Targets Study Steering Committee and Investigators. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease, Mayo Clin Proc, 83, 870-9
  • Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto Jr AM, Kastelein JJP, Koenig W, Libby P, Lorenzati AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, the Jupiter Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195-2207
  • Robinson JG (2008) Should We Use PPAR Agonists to Reduce Cardiovascular Risk?, PPAR research, 2008, 891425 Abstract
  • Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, and the JUPITER Trial Study Group (Dec 2007) Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein., The American journal of cardiology, 100 (11), 1659-64 Abstract
  • Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, for the Treating to New Targets Investigators (Nov 2007) Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study., Clinical journal of the American Society of Nephrology : CJASN, 2 (6), 1131-9 Abstract
  • Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators (Nov 2007) Predicting risk of breast cancer in postmenopausal women by hormone receptor status., Journal of the National Cancer Institute, 99 (22), 1695-705 Abstract
  • Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B, for the Illuminate Investigators (Nov 2007) Effects of torcetrapib in patients at high risk for coronary events., The New England journal of medicine, 357 (21), 2109-22 Abstract
  • Luo J, Margolis KL, Adami HO, Lopez AM, Lessin L, Ye W, Women's Health Initiative Investigators (Oct 2007) Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States)., American journal of epidemiology, 166 (7), 752-9 Abstract
  • LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H, Treating to New Targets Study Steering Committee and Investigators (Sep 2007) Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study)., The American journal of cardiology, 100 (5), 747-52 Abstract
  • Robinson JG (2007) Simvastatin: Present and future perspectives, Expert Opin, Pharmacother, 8 (13), 2159-67
  • Davidson MH, Robinson JG (May 2007) Safety of aggressive lipid management., Journal of the American College of Cardiology, 49 (17), 1753-62 Abstract
  • Robinson JG, Schrott H (2007) Statin Pleiotropy: A popular concept but clinical significance unclear, Cardiovasc Drugs Ther
  • Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR, Women's Helath Initiative Investigators (Feb 2007) Prehypertension and cardiovascular disease risk in the Women's Health Initiative., Circulation, 115 (7), 855-60 Abstract
  • Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, Women's Health Initiative Investigators (Feb 2007) Calcium/vitamin D supplementation and cardiovascular events., Circulation, 115 (7), 846-54 Abstract
  • Robinson JG, Bakris G, Torner J, Stone NJ, Wallace R (2007) Is it time for a cardiovascular primary prevention trial in the elderly?, Stroke, 38 (2), 441-50
  • Robinson JG (2007) Update on PPAR Agonists: The Clinical Significance of FIELD and PROACTIVE, Curr Atheroscler Rep, 9 (1), 64-71
  • Robinson JG, Davidson MJ, Shah A, Lin J, Neff D, DeLucca PT, Tomassini JE, Veltri E, Tershakovec AM (2007) Efficacy and safety of ezetimibe and ezetimibe+statin therapy in patients aged <65, 65-74, and 75 years and older, Aging Health, 3, 691-705
  • Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML, the WHI and WHI CACS Investigators (2007) Estrogen therapy and coronary-artery calcification, N Engl J Med, 356, 2591-602
  • Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK, for Treating to New Targets Study Steering Committee and Investigators (2007) Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease, Ann Intern Med, 147, 1-0
  • Barter P, Gotto A, LaRosa JC, Maroni J, Szarek M, Grundy SM, Katelein JJP, Bittner V, Fruchart J-C for the Treating to New Targets Investigators (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, N Engl J Med, 357, 1301-10
  • Jaramillo SA, Felton D, Andrews L, Desiderio L, Hallarn RK, Jackson SD, Robinson JG, Ockene JK, Coker LH, Espeland MA for the Women's Health Initiative Memory Study Research Group (2007) Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI), Acad Radiol, 14, 603-12
  • Kooperberg C, Cushman M, Hsia J, Robinson JG, Aragaki A, Baird A, Beeresford SA A, Johnson KC, Kuller L, Rodriguez B (2007) Inflammation and thrombosis biomarkers, risk of ischemic stroke, and interactions with hormone treatment in postmenopausal women, PLOS Clin Trials, 2 (6), e28
  • Robinson JG, Davidson M (2007) Investigational drugs targeting HDL metabolism and reverse cholesterol transport, Future Lipidolol, 2, 285-301
  • Robinson JG, Wallace R, Limacher M, Sato A, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG (2006) Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk, J Womens Health, 15 (10), 1151-60
  • Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD, for the Treating to New Targets Investigators (Sep 2006) Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study., Lancet, 368 (9539), 919-28 Abstract
  • Allison M, Garland C, Chlebowski R, Criqui M, Langer R, Wu L, Roy H, McTiernan A, Kuller L, Women's Health Initiative Investigators (Sep 2006) The association between aspirin use and the incidence of colorectal cancer in women., American journal of epidemiology, 164 (6), 567-75 Abstract
  • McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY, Women's Health Initiative Investigators (Sep 2006) Relation of BMI and physical activity to sex hormones in postmenopausal women., Obesity (Silver Spring, Md.), 14 (9), 1662-77 Abstract
  • Robinson JG, Stone NJ (2006) Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids, Am J Cardiol, 98 (4A), 39i-49i
  • Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D, for the Treating to New Targets Investigators (Jun 2006) Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study., Diabetes care, 29 (6), 1220-6 Abstract
  • Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA, Ko MG, Naughton MJ, Satterfield S, Bassford T, Women's Health Initiative Investigators (Jun 2006) Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial., Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 21 (6), 817-28 Abstract
  • Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators (Apr 2006) Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease., American journal of epidemiology, 163 (7), 589-99 Abstract
  • Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Women's Health Initiative Investigators (Feb 2006) Calcium plus vitamin D supplementation and the risk of fractures., The New England journal of medicine, 354 (7), 669-83 Abstract
  • Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R, Women's Health Initiative Investigators (Feb 2006) Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative., Archives of internal medicine, 166 (3), 357-65 Abstract
  • Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE, Women's Health Initiative Investigators (Feb 2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer., The New England journal of medicine, 354 (7), 684-96 Abstract
  • Robinson JG, Stone NJ (2006) Identifying patients for aggressive cholesterol lowering: The risk curve concept, Am J Cardiol, 98, 1405-8
  • Hsia J, Manson JE, Kuller L, Pettinger M, Choe JH, Langer RD, Limacher M, Oberman A, Ockene J, O'Sullivan MJ, Robinson JG, for the Women's Health Initiative (2006) Impact of cyclooxygenase inhibitor use in the Women's Health Initiatve Hormone Trials: Secondary analysis of a randomized trial, PLOS Clin Trials http://dx.doi.org/10.1371/journal.pctr.0010026
  • Robinson JG, Davidson MH (2006) Managing cholesterol in the elderly, Healthy Aging, 2 (4), 623-38
  • Knopp RH, d'Emden M, Smilde JG, Pocock SJ, on behalf of the Aspen Study Group (2006) Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN), Diab Care, 29, 1478-85
  • Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, for the WHISCA Investigators (2006) Coker, LH, Granek IA, Hogan P, Ockene JK, for the WHISCA Investigators. Effects of combination estrogen plus progestin hormone treatment on cognition and affect, J Clin Endocrin Metab, 19, 1802-10
  • Robinson JG, Davidson MH (2006) Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction, Exp Rev Cardiovasc Ther, 4 (4), 461-76
  • Crouse JR III, Elam MB, Robinson JG, Ambrosius WT (2006) Cholesterol Management: Targeting a Lower Low Density Lipoprotein Cholesterol Concentration Increases Adult Treatment Panel - III Goal Attainment, Am J Cardiol, 96, 1667-9
  • Robinson JG, Davidson M (2006) How low to target LDL-cholesterol?, Nature Clinical Practice Endocrinology & Metabolism, 2, 2-3
  • Hsia JA, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McGrae M, Robinson JG (2006) Conjugated equine estrogens and peripheral arterial disease risk, Am J Cardiol, 152, 170-6
  • Davidson M, Robinson JG (2006) Lipid-lowering effects of statins: A comparative review, Exp Opin Pharmacother, 7 (13), 1701-14
  • Robinson JG, Smith B, Maheshwari N, Schrott H (Nov 2005) Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis., Journal of the American College of Cardiology, 46 (10), 1855-62 Abstract
  • Robinson JG, Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis., The New England Journal of Medicine, 353(17), 1858-60; author repl, Oct 2005 Abstract
  • Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Helath Initiative Investigators (Sep 2005) Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial., American journal of epidemiology, 162 (5), 404-14 Abstract
  • Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N, Mason E, Brzyski R, Ockene J, Assaf A, LaCroix A, Matthews K, Wallace R, Women's Health Initiative Investigators (Sep 2005) Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial., Archives of internal medicine, 165 (17), 1976-86 Abstract
  • Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators (May 2005) Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative., Obstetrics and gynecology, 105 (5 Pt 1), 1063-73 Abstract
  • LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets (TNT) Investigators (Apr 2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease, 352 (14), 1425-35
  • Robinson JG, Maheshwari N (Feb 2005) A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years, 95 (3), 373-8
  • Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators (Nov 2004) Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial, 292 (18), 2227-36
  • Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR, Women's Health Initiative Investigators (Oct 2004) Estrogen plus progestin and risk of venous thrombosis., JAMA : the journal of the American Medical Association, 292 (13), 1573-80 Abstract
  • Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV, Women's Health Initiative Investigators (Jul 2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial., Diabetologia, 47 (7), 1175-87 Abstract
  • Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, Women's Health Initiative Investigators (Mar 2004) Estrogen plus progestin and colorectal cancer in postmenopausal women., The New England journal of medicine, 350 (10), 991-1004 Abstract
  • Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM, Women's Health Initiative Investigators (Feb 2004) Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative., Circulation, 109 (5), 620-6 Abstract
  • Kohatsu ND, Robinson JG, Torner JC, Evidence-based public health: an evolving concept, Am J Prev Med, 27(5), 417-21, 2004
  • Waters DD, Guyton JR, Herrington DM, McGowan MP, Wenger NK, Shear C, TNT Steering Committee Members and Investigators (Jan 2004) Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?, The American journal of cardiology, 93 (2), 154-8 Abstract
  • Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM, Women's Health Initiative Investigators (Oct 2003) Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial., JAMA : the journal of the American Medical Association, 290 (13), 1739-48 Abstract
  • Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women's Health Initiative Investigators (Oct 2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial., JAMA : the journal of the American Medical Association, 290 (13), 1729-38 Abstract
  • Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, Dicken T, Oberman A, Sheps DS, Women's Health Initiative Investigators (Sep 2003) Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative., Archives of internal medicine, 163 (17), 2041-50 Abstract
  • Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators (Aug 2003) Estrogen plus progestin and the risk of coronary heart disease., The New England journal of medicine, 349 (6), 523-34 Abstract
  • Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, for the Stellar Study Group (Jul 2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)., The American journal of cardiology, 92 (2), 152-60 Abstract
  • Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG, Women's Health Initiative Investigators (May 2003) Effects of estrogen plus progestin on health-related quality of life., The New England journal of medicine, 348 (19), 1839-54 Abstract
  • Robinson JG, Conroy C, Wickemeyer WJ, Comparison of effectiveness and safety of simvastatin in patients <75 versus > or =75 years of age with coronary, cerebral, or peripheral arterial disease, The American Journal of Cardiology, 90(9), 994-5, November 2002 Abstract
  • Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB, Hanson KB, Robinson JG, Alekel DL, Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors, Journal of Nutrition, 131(9), 2280-7, September 2001 Abstract
  • St Germain A, Peterson CT, Robinson JG, Alekel DL, Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment, Menopause (new York, N.y.), 8(1), 17-26, 2001 Abstract
  • Robinson JG, Boland LL, McGovern PG, Folsom AR for the ARIC Investigators, Comparison of NCEP guidelines and Framingham-based risk estimates in a population-based cohort, Prev Cardiol, 4, 148-157, 2001
  • Robinson JG, Conroy C, Wickemeyer WJ, A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol < or = 100 mg/dl, The American Journal of Cardiology, 85(3), 305-8, February 2000 Abstract
  • Robinson JG, Prevention of another coronary event, Iowa Medicine, 87, 283-284, 1997
  • Robinson JG, Folsom AR, Nabulsi AA, for the ARIC Investigators, Can postmenopausal hormone replacement benefit plasma lipids in women with diabetes?, Diabetes Care, 19, 480-485, 1996
  • Robinson JG, Body fat and body image in women runners, Melpomene Inst Women Health Res, Spring, 1987

Profile Details

Last Updated: 9/10/2009

COS Expertise ID #1111547
Reference this profile directly: http://myprofile.cos.com/jgrobinson